Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Pathobiology 2026

All other abstracts will be scheduled into poster sessions that will be held in late afternoon with no competing platform sessions to ensure that all attendees can participate in the poster discussions. Further, each poster session will be preceded...

IMFINZI plus neoadjuvant EV improved survival outcomes in muscle-invasive bladder cancer in the Phase III VOLGA trial

trend for OS; however, the OS data were not statistically significant at this planned interim analysis and will be formally reassessed at a subsequent analysis. Approximately one in four patients with bladder cancer has muscle-invasive disease,...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

membrane oxygenation (ECMO) intervention. "Pupillary assessment is one of the key neurologic checks we can perform quickly and repeatedly at the bedside, but the traditional penlight exam has important limitations," says Olson. "NPi pupillometry...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

to the function of tissues, organs, and physiological systems, influencing metabolism, immune function, and physical performance. Tetraselmis chuii was first identified in the 1950s and has long been used in aquaculture due to its rich nutritional...

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

growth initiatives, building strong partnerships with global pharmaceutical companies, and enhancing organizational performance across the business. In her role, McCullough Wood will lead Avid's global commercial organization, including business...

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

and supporting medical teams with the purpose of achieving superior outcomes for patients and their families. For more information please Visit www.partnertx.com.

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL. Restoration (BEAR®) Implant, announced Jamal Rushdy has been selected as the...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

vials. “We are proud to continue expanding our portfolio with the addition of Tranexamic Acid in a ready-to-use format,” said Jeff Yordon, Co-Founder and CEO of Avenacy. “This presentation enables healthcare providers to deliver safe and efficient...

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

adequate folate status in both mother and baby. "This study allows us to directly compare how different supplemental forms of folate are processed during pregnancy," said Dr. Xinyin Jiang, a professor of health and nutrition sciences at Brooklyn...

Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

gene therapies, announced today a partnership with Elaaj Bio, a biotechnology company focused on development of transformative treatments for CDKL5 Deficiency Disorder (CDD). Elaaj Bio is a wholly owned subsidiary of the Loulou Foundation, a private...

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

medications by date and time into convenient packets, then delivers them to customers’ doors at no extra cost. For more information please visit, www.amazon-pharmacy.com

Study Finds Testosterone Therapy Boosts Women’s Energy, Mood, and Quality of Life

Joi + Blokes, a telehealth platform specializing in diagnostic testing, personalized medicine, and hormone and menopause care, announced the publication of a new peer-reviewed study demonstrating that testosterone replacement therapy (TRT) in...

BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) Execute Heads of Terms to Accelerate Global Expansion of CAR T-Cell Therapy

in New Zealand and Australia (ENABLE-2, NCT06486051) BioOra's automated manufacturing process, utilising the Cocoon ® platform developed by the Octane Medical Group, is a core competitive advantage, enabling more consistent, scalable, and...

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

company collaborates with leading breast milk and microbiome researchers to bring cutting-edge science to families. Across formulation and manufacturing, NurtureBio applies a research-first standard, including collaboration with academic partners...

2nd Annual MaxPotent Pharma Summit 2026

2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...

Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research

currently supports clinical trials in at least 18 countries across the Americas, Asia, Australia, and Europe. For more information please visit, www.infocusclinical.com

TruLeaf Medical Completes Second-Stage Valve Implantation in Two Patients

refractory heart failure due to leaky tricuspid valve (TR). The first stage of the docking device implantation was performed 3 months ago. In recent days, the second stage of fully percutaneous transcatheter heart valve implantation within the...

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

also at high risk for these events.1 Oral semaglutide for type 2 diabetes has been available as Rybelsus® in a different formulation and set of doses. "Ozempic® has become a leading, trusted brand for people with type 2 diabetes and the science is...

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

Jakafi XR tablet taken once-daily (QD) is bioequivalent to a single 25 mg Jakafi tablet, the immediate-release (IR) dosage form, taken twice-daily (BID). This means that, based on key measures of steady-state drug exposure, it delivers the same...

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

indications. The acquisition of Candid builds on UCB’s recently announced transaction with Antengene and reflects a platform-driven strategy in next-generation immunology. Together, these complementary investments expand UCB’s reach across multiple...